Validation of a French Quality of Life Questionnaire Adapted to Persons Who Have Suffered a Stroke

Development and Validation of a French Quality Of Life Scale Specific to Patients Who Have Suffered a Stroke

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02855970

Acronym

QUALI STROKE

Enrollment

Registered

2016-08-04

Start date

2015-02-16

Completion date

Unknown

Last updated

2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The aim of this work is to develop and validate a scale adapted to French cultural characteristics. It will be based on the SS-QoL scale and be simple and quick to use in everyday practice. It is not simply a translation. This transcultural adaptation requires linguistic and psychometric validation, by studying its validity, its reliability and its sensitivity to change, as though it were a new instrument. The investigators will then develop a short version by reducing the items and conduct a psychometric validation. The translation and validation of a short French version of the SS-QoL scale will generate a reliable and sensitive, easy-to-use tool suitable for use in everyday practice. The final objective is to use this tool as a principal judgement criterion in future therapeutic trials and in patients of the Dijon Stroke Registry to bring to light prognostic factors that affect quality of life so as to provide better management of this disease.

Interventions

OTHERcompletion of a quality of life questionnaire

Study design

Allocation

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients aged 18 years and older. * Patients following a first stroke (ischemic or non-traumatic cerebral parenchyma haemorrhage) followed at a consultation at Dijon CHU and included in the Dijon Stroke Registry cohort. * Patients who have provided oral informed consent. * Patients with national health insurance cover

Exclusion criteria

* History of symptomatic stroke. * Meningeal haemorrhage. * Severe visual or hearing handicap making it difficult to complete the questionnaire. * Global severe aphasia and mutism making communication with the patient impossible-. * Unable to read or speak French. * Dementia prior to the stroke. * Psychiatric disorders and dependence on alcohol/drugs. * Bedridden before the stroke. * Other comorbidities considered severe by the clinician and not related to the stroke that could have significantly impaired quality of life before the stroke.

Design outcomes

Primary

Measure	Time frame
responses to a quality of life questionnaire	Change compared with baseline score at Day 15, Day 60

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026